Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 9,000 shares at $45.71 ($419K) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Open-market sale of $419k INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.71 | 2,415 | $110K | 26.4% |
| 2 | $46.65 | 5,200 | $243K | 57.9% |
| 3 | $47.43 | 1,385 | $66K | 15.7% |
| Total | $46.52 avg | 9,000 | $419K | 100% |
| Filing → |
| INCR | SELL | 2016-03-02 | $359K | — | Filing → |
| INCR | SELL | 2016-02-02 | $365K | — | Filing → |
| INCR | SELL | 2016-01-06 | $421K | — | Filing → |